Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4606 to 4620 of 8211 results

  1. NICE encourages further research, preferably randomised controlled trials, into percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis access. This should report details of patient selection, particularly about vascular anatomy, technique used, need for training, patency of the fistula and its subsequent ease of use, and quality of life.

    Recommendation ID IPG710/01 Question NICE encourages further research, preferably randomised controlled trials, into percutaneous endovascular

    Research recommendation
    Published
    5 November 2021

  2. NICE encourages research into endovascular stentgrafting of popliteal aneurysms and may review this procedure on publication of further evidence.

    Recommendation ID IPG390/1 Question NICE encourages research into endovascular stentgrafting of popliteal aneurysms and may review this

    Research recommendation
    Published
    9 June 2015

  3. NICE encourages the company, NHS England and treatment centres to collect more evidence, particularly on the longer-term benefits and costs of eliglustat and enzyme replacement therapy for treating type 1 Gaucher disease.

    Recommendation ID HST5/1 Question NICE encourages the company, NHS England and treatment centres to collect more evidence, particularly

    Research recommendation
    Published
    12 October 2018

  4. What is the effectiveness and safety of regimens using mifepristone and misoprostol for women who are having medical abortion after 23 +6  weeks' gestation, particularly for those who have had a previous caesarean section or uterine surgery?

    Recommendation ID NG140/6 Question What is the effectiveness and safety of regimens using mifepristone and misoprostol for women who are

    Research recommendation
    Published
    8 November 2019

  5. Medication choice in people with coexisting conditions:- What is the clinical and cost effectiveness of ADHD medications in people with ADHD and tic disorders, a history of psychosis or mania, or personality disorder?

    Recommendation ID NG87/2 Question Medication choice in people with coexisting conditions:- What is the clinical and cost effectiveness

    Research recommendation
    Published
    14 November 2018

  6. Medication choice in people with no previous medication for ADHD:- What is the clinical and cost effectiveness of ADHD medications in people with ADHD with noprevious medication for the condition?

    Recommendation ID NG87/3 Question Medication choice in people with no previous medication for ADHD:- What is the clinical and cost effectiveness

    Research recommendation
    Published
    14 November 2018

  7. Medication for promoting de-escalation:- Which medication is effective in promoting de-escalation in people who are identified as likely to demonstrate significant  violence?

    Recommendation ID NG10/1 Question Medication for promoting de-escalation:- Which medication is effective in promoting de-escalation in

    Research recommendation
    Published
    5 October 2015

  8. What interventions are effective to support medicines adherence for people with complex psychosis in supported accommodation?

    Recommendation ID NG181/9 Question What interventions are effective to support medicines adherence for people with complex psychosis in

    Research recommendation
    Published
    26 October 2020

  9. For which service users who are moderately and severely dependent on alcohol is an assertive community treatment model a clinically and cost-effective intervention compared with standard care?

    Recommendation ID CG115/4 Question For which service users who are moderately and severely dependent on alcohol is an assertive community

    Research recommendation
    Published
    9 June 2015

  10. FRAX and QFracture in adults living in residential care:- What is the utility of FRAX and QFracture in detecting risk of fragility fracture in adults living in residential care?

    Recommendation ID CG146/5 Question FRAX and QFracture in adults living in residential care:- What is the utility of FRAX and QFracture

    Research recommendation
    Published
    9 June 2015

  11. FRAX and QFracture in adults receiving bone protective therapy:- What is the utility of FRAX and QFracture in adults receiving bone protective therapy?

    Recommendation ID CG146/2 Question FRAX and QFracture in adults receiving bone protective therapy:- What is the utility of FRAX and QFracture

    Research recommendation
    Published
    9 June 2015

  12. FRAX and QFracture in adults with secondary causes of osteoporosis:- What is the utility of FRAX and QFracture in detecting risk of fragility fracture in adults with secondary causes of osteoporosis?

    Recommendation ID CG146/3 Question FRAX and QFracture in adults with secondary causes of osteoporosis:- What is the utility of FRAX and

    Research recommendation
    Published
    9 June 2015

  13. What are the benefits of planned, regular community-based reviews compared with as-required review of non-cancer patients approaching the end of their life?

    Recommendation ID NG142/3 Question What are the benefits of planned, regular community-based reviews compared with as-required review of

    Research recommendation
    Published
    18 November 2019

  14. Frequency of monitoring: For adults, children and young people with CKD, what is the optimal monitoring frequency for albumin:creatinine ratio?

    Recommendation ID NG203/9 Question Frequency of monitoring: For adults, children and young people with CKD, what is the optimal monitoring

    Research recommendation
    Published
    30 September 2021

  15. Frequency of monitoring:- How frequently should children be measured to identify faltering growth?

    Recommendation ID NG75/4 Question Frequency of monitoring:- How frequently should children be measured to identify faltering growth?

    Research recommendation
    Published
    15 October 2018